---
layout: post
title: "Grant of Interim Extension of the Term of U.S. Patent No. 7,517,522; Recombinant ADAMTS13 (rADAMTS13), a Recombinant A Disintegrin and Metalloprotease With Thrombospondin Type-1 Motifs 13"
date: 2026-02-05 18:55:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-13707
original_published: 2023-06-28 00:00:00 +0000
significance: 8.00
---

# Grant of Interim Extension of the Term of U.S. Patent No. 7,517,522; Recombinant ADAMTS13 (rADAMTS13), a Recombinant A Disintegrin and Metalloprotease With Thrombospondin Type-1 Motifs 13

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** June 28, 2023 00:00 UTC
**Document Number:** 2023-13707

## Summary

The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 7,517,522 ('522 patent).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/06/28/2023-13707/grant-of-interim-extension-of-the-term-of-us-patent-no-7517522-recombinant-adamts13-radamts13-a)
- API: https://www.federalregister.gov/api/v1/documents/2023-13707

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
